Flow-Representation Approach For ICMPV6-Based Ddos Attacks Detection

In addition to the address expandability, IPv6 broughts new functionalities, such as Neighbor Discovery Protocol (NDP) and address auto-configuration scheme, which depends on Internet Control Message Protocol version 6 (ICMPv6) protocol. ICMPv6 is delegated with more responsibilities than Internet Control Message Protocol version 4 (ICMPv4) in IPv4, and it is considered the backbone and the mandatory part in IPv6 native networks. IPv6 is vulnerable to a number of attacks from IPv4, besides new attacks have appeared within its new features. The most popular IPv6 attacks are Denial of Service (DoS) and its distributed version (DDoS) that use ICMPv6 messages. ICMPv6-based DoS & DDoS attacks are one of the major problems of today’s Internet, impacting economic damages in some serious cases

Flow-Based IDS for ICMPv6-Based DDoS Attacks Detection

The Internet Control Message Protocol version Six (ICMPv6) is categorized as the most important part of the Internet Protocol version Six (IPv6) due to its core functionalities. However, ICMPv6 protocol is vulnerable to different types of attacks such as Distributed Denial of Services (DDoS) attacks that are based on ICMPv6 messages. ICMPv6-based DDoS attacks are the most performed attacks against IPv6 networks and considered a grave problem of today Internet. Intrusion Detection Systems (IDSs) under different categories have been proposed to detect ICMPv6-based DDoS attacks. However, these IDSs are inefficient in detecting the attacks due to their limitations. The main limitation of the existing IDSs is the dependency on packet-based representation and features which are unsuitable for detecting DDoS attacks as experimentally proven. Therefore, this research proposes a new IDS, based on a flow

Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study

OBJECTIVES: Paediatric cancer is a leading cause of death for children. Children in low-income and middle-income countries (LMICs) were four times more likely to die than children in high-income countries (HICs). This study aimed to test the hypothesis that the COVID-19 pandemic had affected the delivery of healthcare services worldwide, and exacerbated the disparity in paediatric cancer outcomes between LMICs and HICs. DESIGN: A multicentre, international, collaborative cohort study. SETTING: 91 hospitals and cancer centres in 39 countries providing cancer treatment to paediatric patients between March and December 2020. PARTICIPANTS: Patients were included if they were under the age of 18 years, and newly diagnosed with or undergoing active cancer treatment for Acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, Wilms' tumour, sarcoma, retinoblastoma, gliomas, medulloblastomas or neuroblastomas, in keeping with the WHO Global Initiative for Childhood Cancer. MAIN OUTCOME MEASURE: All-cause mortality at 30 days and 90 days. RESULTS: 1660 patients were recruited. 219 children had changes to their treatment due to the pandemic. Patients in LMICs were primarily affected (n=182/219, 83.1%). Relative to patients with paediatric cancer in HICs, patients with paediatric cancer in LMICs had 12.1 (95% CI 2.93 to 50.3) and 7.9 (95% CI 3.2 to 19.7) times the odds of death at 30 days and 90 days, respectively, after presentation during the COVID-19 pandemic (p<0.001). After adjusting for confounders, patients with paediatric cancer in LMICs had 15.6 (95% CI 3.7 to 65.8) times the odds of death at 30 days (p<0.001). CONCLUSIONS: The COVID-19 pandemic has affected paediatric oncology service provision. It has disproportionately affected patients in LMICs, highlighting and compounding existing disparities in healthcare systems globally that need addressing urgently. However, many patients with paediatric cancer continued to receive their normal standard of care. This speaks to the adaptability and resilience of healthcare systems and healthcare workers globally